Hematological Malignancies Market: Emergence of Effective Therapeutics and Drugs to Encourage Growth
The global market for hematological malignancies is highly competitive in nature and is characterized by a consolidated nature, owing to the presence of a few players holding a large share of the overall market, states a research study by Transparency Market Research. The leading players operating in the global market, including Roche, Celgene, Novartis, and AbbVie are anticipated to remain dominant throughout the forecast period. In order to maintain their position and sustain in the competitive environment, the global market...
View full press release